Literature DB >> 1121058

Immunological aspects of aortitis syndrome.

I Ito, Y Saito, Y Nonaka.   

Abstract

1. Anti-aortic antibodies were frequently detected from the sera of patients with aortitis syndrome. 2. Aortic antigens were demonstrated to exist mainly in the media. The antigenicity was inactivated by collagenase, trypsin and pepsin, but not by DNase-I. Analyses of aortic antigens were also made by ultracentrifugation and column chromatography. 3. Experimental arteritis could be produced in animals by isologous active immunization and heterologous passive immunization. 4. From these results, participation of antigen-antibody reaction in the development of the disease has been speculated. Possible role of streptococcal infection as one of the trigger mechanisms in antibody production has been suggested in combination with evidence indicating hypersensitivity of the patients to infections.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1121058     DOI: 10.1253/jcj.39.459

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  5 in total

Review 1.  An overview on Takayasu arteritis.

Authors:  M Sekiguchi; J Suzuki
Journal:  Heart Vessels Suppl       Date:  1992

2.  [33-year old patient with thoraco-abdominal pain and differences of blood pressure].

Authors:  F Hanses; U Müller-Ladner; J Schölmerich; A Schäffler
Journal:  Internist (Berl)       Date:  2004-12       Impact factor: 0.743

Review 3.  Does a common pathophysiological basis exist in the association of ulcerative colitis and Takayasu's aortitis? Report of a case.

Authors:  H Ikenaga; T Ogihara; S Iyori; S Kou; H Yoshikawa; M M Okura
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

4.  Surgical and immunological aspects of Takayasu's disease.

Authors:  S Gupta
Journal:  Ann R Coll Surg Engl       Date:  1981-09       Impact factor: 1.891

5.  Takayasu's arteritis associated with idiopathic ulcerative colitis.

Authors:  V Sakhuja; K L Gupta; D K Bhasin; N Malik; K S Chugh
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.